Stephen T Worland - Net Worth and Insider Trading
Stephen T Worland Net Worth
The estimated net worth of Stephen T Worland is at least $58,766 dollars as of 2024-04-27. Stephen T Worland is the President and Chief Executive of eFFECTOR Therapeutics Inc and owns about 31,093 shares of eFFECTOR Therapeutics Inc (EFTR) stock worth over $58,766. Details can be seen in Stephen T Worland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen T Worland has not made any transactions after 2022-06-07 and currently still holds the listed stock(s).
Transaction Summary of Stephen T Worland
Stephen T Worland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen T Worland owns 3 companies in total, including TRACON Pharmaceuticals Inc (TCON) , GenMark Diagnostics Inc (GNMK) , and eFFECTOR Therapeutics Inc (EFTR) .
Click here to see the complete history of Stephen T Worland’s form 4 insider trades.
Insider Ownership Summary of Stephen T Worland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2015-02-25 | director |
| GNMK | GenMark Diagnostics Inc | 2014-05-29 | director |
| EFTR | eFFECTOR Therapeutics Inc | 2022-06-07 | director & President and Chief Executive |
Stephen T Worland Latest Holdings Summary
Stephen T Worland currently owns a total of 1 stock. Stephen T Worland owns 31,093 shares of eFFECTOR Therapeutics Inc (EFTR) as of June 7, 2022, with a value of $58,766.
Latest Holdings of Stephen T Worland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EFTR | eFFECTOR Therapeutics Inc | 2022-06-07 | 31,093 | 1.89 | 58,766 |
Holding Weightings of Stephen T Worland
Stephen T Worland Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen T Worland has made a total of 1 transactions in eFFECTOR Therapeutics Inc (EFTR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in eFFECTOR Therapeutics Inc is the acquisition of 800 shares on June 7, 2022, which cost Stephen T Worland around $27,400.
Insider Trading History of Stephen T Worland
- 1
Stephen T Worland Trading Performance
GuruFocus tracks the stock performance after each of Stephen T Worland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen T Worland is -58.5%. GuruFocus also compares Stephen T Worland's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen T Worland within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen T Worland's insider trading performs compared to the benchmark.
Performance of Stephen T Worland
Average Return
-0.77%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.69 | -58.5 | -69.72 | -0.77 | ||
| Relative Return to S&P 500(%) | 13.89 | -54.15 | -64.27 | -3.34 |
Stephen T Worland Ownership Network
Ownership Network List of Stephen T Worland
Ownership Network Relation of Stephen T Worland
Stephen T Worland Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Stephen T Worland is the director of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Stephen T Worland made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net purchase of 114,899 shares made by Charles Theuer , a net sale of 4,423,539 shares made by Opaleye Management Inc. , and a net purchase of 3,500 shares made by Scott B. Brown .
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,283 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 23,020 shares were bought by its insiders, resulting in a net sale of 215,263 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Stephen T Worland Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen T Worland. You might contact Stephen T Worland via mailing address: 9050 Camino Santa Fe, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
